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Abstracts: The 16th International Congress on Nutrition and Metabolism in Renal Disease 2012 A25dietitians.Control groups:Regular face to face counseling as well as attentions
in follow-up is conducted by dietitians.Time arrangement for follow-up,3
times within 24 weeks (week 4, 12 and 24 respectively).180 cases completed
the trail. Compared with control group, the test group patients’s compliance
with DPI was better, 58.576.8 gvs45.678.9 g po0.05).The knowledge of
diet protein score was higher than the control group, 19.474.5 vs
11.373.2,Po0.01).The clinical data still had no difference.In Conclusion,the
DPE is a new good tool for Chinese CKD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.35936
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Purpose: Preservation of residual renal function (RRF) in peritoneal
dialysis patient is essential to improve clinical outcomes. Therefore, we
conducted a prospective observational study to investigate the effect of low
RRF in early period on body composition changes in CAPD patients.
Methods: Among new diabetic CAPD patients from May 2001 to December
2009 in our hospital, 92 patients who ﬁnished 12 month protocol (male:
48, mean age: 54.0711.0 years) were analyzed. Patients were assigned to
4 different dialysis solution (Dianealsn¼30, Physionealsn¼15 and Stay-
safesn¼15, Stay-safe Balances, n¼32). We deﬁned the early low RRF
group (n¼10) as less than 1.5 ml/min 1.73 m2 at 4 weeks after initiation of
peritoneal dialysis. Daily ultraﬁltration volume (UFV) and urine volume
(UV), daily peritoneal glucose absorption, adequacy, residual renal function
(RRF) and clinical indices were measured at 4 weeks and 12 months. The
peritoneal equilibration test (PET) were performed at 4 weeks and 12
months. Body composition including body weight (BW), lean body mass
(LBM) and fat mass were measured using bio-impedance analysis (BIA) at
4 weeks and 12 months. Delta LBM was calculated as LBM at 12 months
minus LBM at 4 weeks. We analyzed the data by SPSS 17.0. Results: 1)
Baseline characteristics between the early low RRF group and the non-early
low RRF group were not signiﬁcantly different. 2) There was signiﬁcant
positive correlation between RRF at 4 weeks and RRF at 12 months
(po0.01). 3) The early low RRF group showed signiﬁcant lower delta LBM
than non-early low RRF group (3.1 vs. 0.95 kg, po0.05) There were no
signiﬁcant differences in body weight and fat mass between the two
groups. 4) The early low RRF group showed signiﬁcant lower serum
albumin than non-early low RRF group (3.25 vs. 3.59 g/dl, po0.05) at 12
months. Conclusions: The low RRF in early period of peritoneal dialysis
might be associated with body composition changes during the ﬁrst year in
CAPD patients. It is suggested that preservation of RRF in early period of
peritoneal dialysis is important to improve nutritional status.
http://dx.doi.org/10.1016/j.krcp.2012.04.36037
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A protein-restricted diet with keto/amino acids (KA) supplement showed
favorable effects on delayed renal replacement therapy in patients with
chronic kidney disease. This is an open, prospective, randomized, and
multi-center study. A total of 67 patients were randomly assigned into two
groups. LPDþKA group was advised to take less than 0.6 g/kg/day of
protein with KAs. LPD group was advised to consume less than 0.6 g/kg/day
protein. Nutritional and clinical parameters were evaluated at baseline,
3 and 6 months. Nutritional status represented as body mass index, mid-
arm circumference and triceps skin-fold thickness was not differentbetween the two groups at 3months and 6 months. Ca P product level
measured at 3 months was lower in the LPDþKA group than in the LPD
group (LPDþKA group: 33.575.0 vs. LPD group: 36.977.9 mg2/dL2,
po0.05). The slope of the glomerular ﬁltration rate (GFR slope) and the
percentage of the GFR slope (GFR slope %) at 3 months were more
preserved in the LPDþKA group than in the LPD group. The GFR slope and
GFR slope % at 6 months were not signiﬁcantly different. In the entire
subjects, the GFR slope was negatively correlated with Ca P product
levels at 3 months, total cholesterol at baseline, and urine protein-
creatinine ratio at baseline and 6 months (r¼0.255, r¼0.296, r
¼0.412, r¼0.371, po0.05). A multiple regression analysis revealed
CaP product at 3 months was the only independent factor affecting the
GFR slope at 3 months. The present study suggests that a low protein diet
supplemented with KA had a beneﬁcial effect on preserving renal function
and improving calcium and phosphorus disturbances in patients with
chronic kidney disease.
http://dx.doi.org/10.1016/j.krcp.2012.04.36138
DOSE BODY FAT MASS DEFINE SURVIVAL IN PATIENTS STARTING
PERITONEAL DIALYSIS?
Soo Jeong Choi, Soon Mi Hur, Kyong-Ah Park, Moo Yong Park, Jin Kuk Kim,
Seung Duk Hwang
Soonchunhyang Universtiy Bucheon Hospital, Bucheon-si, Gyeonggi-do, South
Korea
Peritoneal dialysis (PD) is characterized by a gain in fat mass. In contrast
to subcutaneous fat, visceral fat is associated with metabolic syndrome and
survival. We prospectively examined whether the visceral or subcutaneous
fat could deﬁne outcomes in patients undergoing PD. We studied 105 new
patients (51 males) undergoing PD between February 2006 and April 2011.
Baseline body composition was measured by computed tomogram.
Visceral and subcutaneous obesity are deﬁned as a visceral fat area
41100 cm2 and subcutaneous fat area 41130 1cm2, respectively. Thirty-
three and 25 patients were diagnosed with visceral and subcutaneous
obesity, respectively. Nineteen patients had both visceral and
subcutaneous obesity. The 1-year and 5-year survival rates were 91% and
75%, respectively. The peritonitis and exit infection rates were 0.36 and
0.13/patient-year, respectively. Patients with visceral obesity had poor
outcomes compared with those without visceral obesity (p¼0.025).
Subcutaneous obesity was not associated with peritonitis or survival. A
multivariate Cox regression analysis did not show that visceral obesity was
a risk factor of poor outcome. Increased visceral fat at the initiation of PD is
not an independent predictor of poor outcome. The impact of visceral or
subcutaneous mass for outcomes in patients undergoing PD would be
better deﬁned by large and long term studies.
http://dx.doi.org/10.1016/j.krcp.2012.04.362
